The Brave New World of Neuroimmune Biology

New Insights to Neuroimmune Biology

Volumn , Issue , 2010, Pages 3-30

  Berczi, Istvan ^a   Quintanar Stephano, Andres ^b   Kovacs, Kalman ^c  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSIDAD AUTÓNOMA DE AGUASCALIENTES   (Mexico)

^c ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882403054     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-384691-4.00001-8     Document Type: Chapter

References (125)

1. A Szentivanyi, I Berczi, H Nyanteh and A Goldman (2003) History. I Berczi, A Szentivanyi (Eds) Neuroimmune biology, vol. 3: the immune–neuroendocrine circuitry. History and progress Amsterdam: Elsevier 7-14.
2. EA Korneva (2010) On the history of immunophysiology: first steps and main trends. I Berczi (Eds) New insights to neuroimmune biology Amsterdam: Elsevier
3. G Filipp, A Szentivanyi and B Mess (1952) Anaphylaxis and nervous system. Acta Med Hung 2 163-173.
4. A Szentivanyi and G Filipp (1958) Anaphylaxis and the nervous system. Part II. Ann Allergy 16 143-151.
5. G Filipp and A Szentivanyi (1958) Anaphylaxis and the nervous system. Part III. Ann Allergy 16 306-311.
6. A Szentivanyi and J Szekely (1956) Effect of injury to, and electrical stimulation of, hypothalamic areas on anaphylactic and histamine shock of the guinea pig. A preliminary report. Ann Allergy 14 259-261.
7. EA Korneva and LM Khai (1964) Effect of destruction of hypothalamic areas on immunogenesis. Fed Proc 23 T88.
8. H Selye (1936) A syndrome produced by diverse nocuous agents. Nature (Lond) 138 32.
9. H Selye (1936) Thymus and adrenals in the response of the organism to injuries and intoxication. Br J Exp Path 17 234-248.
10. H Selye (1946) The general adaptation syndrome and the diseases of adaptation. J Clin Endocrinol 6 117-230.
11. E Nagy and I Berczi (1978) Immunodeficiency in hypophysectomized rats. Acta Endocrinol 89 530-537.
12. E Nagy, I Berczi, GE Wren, SL Asa and K Kovacs (1983) Immunomodulation by bromocriptine. Immunopharmacology 6 231-243.
13. I Berczi (1986) Immunoregulation by the pituitary gland. I Berczi (Eds) Pituitary function and immunity Boca Raton, FL: Monograph published by CRC Press, Inc 227-240.
14. HO Besedovsky and A del Rey (2008) Processing of cytokine signals at CNS levels: relevance for immune–HPA axis interactions. A del Rey, G Chrousos, H Besedovsky, I Berczi, A Szentivanyi (Eds) The hypothalamus–pituitary–adrenal axis Amsterdam: Elsevier 227-240.
15. V Rettori, J Jurcovicova and SM McCann (1987) Central action of interleukin-1 in altering the release of TSH, growth hormone, and prolactin in the male rat. J Neurosci Res 18(1), 179-183.
16. R Ader (1974) Letter: behaviorally conditioned immunosuppression. Psychosom Med 36(2), 183-184.
17. RM Gorczynski and M Kennedy (1984) Associative learning and regulation of immune responses. Prog Neuropsychopharmacol Biol Psychiatry 8(4–6), 593-600.
18. Gorczynski LY, Gorczynski RM. Conditioning of immune reactions. In: Arnason BG, Berczi I, editors; Berczi I, series editor. The brain and host defense. Neuroimmune biology, vol. 9. Amsterdam: Elsevier; 2010.
19. Berczi I, Gorczynski R, editors; Berczi I, Szentivanyi A, series editor. Neuroimmune biology, vol. 1. New foundation of biology. Amsterdam: Elsevier; 2001.
20. I Berczi (2007) Integration and regulation of higher organisms by the neuroimmune supersystem. Int J Integrative Biol 1(3), 216-231.
21. I Berczi (1993) Neuroendocrine defence in endotoxin shock. A review. Acta Microbiol Hung 40 265-302.
22. I Berczi (1998) Neurohormonal host defence in endotoxin shock. Ann NY Acad Sci 840 787-802.
23. I Berczi (1998) The stress concept and neuroimmunoregulation in modern biology. Ann NY Acad Sci 851 3-12.
24. I Berczi, DA Chow and ER Sabbadini (1998) Neuroimmunoregulation and natural immunity. Domestic Anim Endocrin 15 273-281.
25. I Berczi, L Bertok and DA Chow (2001) Natural immunity and neuroimmune host defence. Ann NY Acad Sci 917 248-257.
26. I Berczi and A Szentivanyi (2003) The acute phase response. I Berczi, A Szentivanyi (Eds) Neuroimmmune biology, vol. 3: the immune–neuroendocrine circuitry. History and progress Amsterdam: Elsevier 463-494.
27. I Berczi, A Quintanar-Stephano and K Kovacs (2006) Immunoconversion in the acute phase response. NP Plotnikoff, RE Faith, AJ Murgo, RA Good (Eds) Cytokines, stress and immunity Boca Raton FL, USA: CRC Press, Taylor & Francis Group 215-254. [chapter 14]
28. I Berczi, A Quintanar Stephano and K Kovacs (2009) Neuroimmune regulation in immunocompetence, acute illness and healing. Ann NY Acad Sci 1153 220-239. [Review]
29. RN Ramachandra, AH Sehon and I Berczi (1992) Neuro-hormonal host defence in endotoxin shock. Brain Behav Immun 6 157-169.
30. Korneva EA, Novikova NS. Brain responses to antigenic challenges. In: Arnason BG, Berczi I, editors; Berczi I, series editor. The brain and host defense. Neuroimmune biology, vol. 9. Amsterdam: Elsevier; 2010.
31. I Berczi (2010) Antigenic recognition by the brain: the brain as an immunocompetent organ. I Berczi (Eds) New insights to neuroimmune biology Amsterdam: Elsevier 145-160.
32. JM Williams, RG Peterson, PA Shea, JF Schmedtje, DC Bauer and DL Felten (1981) Sympathetic innervation of murine thymus and spleen: evidence for a functional link between the nervous and immune systems. Brain Res Bull 6(1), 83-94.
33. Jancso G, Katona M, Horvath V, Santa P, Nagy J. Sensory nerves as modulators of cutaneous inflammatory reactions in health and disease. In: Jancso G, editor; Berczi I, Szentivanyi A, series editors. Neurogenic inflammation in health and disease. Neuroimmune biology, vol. 8. Amsterdam: Elsevier; 2008. p.3–38.
34. DM McKay and J Bienenstock (1994) The interaction between mast cells and nerves in the gastrointestinal tract. Immunol Today 15(11), 533-538.
35. A Szentivanyi (1968) The beta adrenergic theory of the atopic abnormality in bronchial asthma. J Allergy 42 203-232.
36. Blatteis CM. Fever as a host defense mechanism. In: Arnason BG, Berczi I, editors; Berczi I, series editor. The brain and host defense. Neuroimmune biology, vol. 9. Amsterdam: Elsevier; 2010.
37. Pavlov VA, Ulloa L, Metz CN. Infection and sepsis. In: Arnason BG, Berczi I, editors; Berczi I, series editors. The brain and host defense. Neuroimmune biology, vol. 9. Amsterdam: Elsevier; 2010.
38. I Berczi, E Nagy, K Kovacs and E Horvath (1981) Regulation of humoral immunity in rats by pituitary hormones. Acta Endocrinol 98 506-513.
39. F Benigni, G Fantuzzi, S Sacco, M Sironi, P Pozzi, CA Dinarello, et al. (1996) Six different cytokines that share GP130 as a receptor subunit, induce serum amyloid A and potentiate the induction of interleukin-6 and the activation of the hypothalamus–pituitary–adrenal axis by interleukin-1. Blood 87(5), 1851-1854.
40. Dhabhar FS. Enhancing versus suppressive effects of stress on immune function: implications for immunoprotection and immunopathology. In: del Rey A, Chrousos G, Besedovsky H, editors; Berczi I, Szentivanyi A, series editors. The hypothalamus–pituitary–adrenal axis. Amsterdam: Elsevier; 2008. p. 207–24.
41. V Chesnokova and S Melmed (2002) Minireview: neuro-immuno–endocrine modulation of the hypothalamic–pituitary–adrenal (HPA) axis by gp130 signaling molecules. Endocrinology 143(5), 1571-1574.
42. SM McCann, M Kimura, A Walczewska, S Karanth, V Rettori and WH Yu (1998) Hypothalamic control of FSH and LH by FSH-RF, LHRH, cytokines, leptin and nitric oxide. Neuroimmunomodulation 5(3–4), 193-202.
43. IC Chikanza (1999) Prolactin and neuroimmunomodulation: in vitro and in vivo observations. Ann NY Acad Sci 22(876), 119-130.
44. M Skurlova, A Stofkova and J Jurcovicova (2006) Exogenous IL-1beta induces its own expression, but not that of IL-6 in the hypothalamus and activates HPA axis and prolactin release. Endocr Regul 40(4), 125-128.
45. P Cano, DP Cardinali, V Jimenez, MP Alvarez, RA Cutrera and AI Esquifino (2005) Effect of interferon-gamma treatment on 24-hour variations in plasma ACTH, growth hormone, prolactin, luteinizing hormone and follicle-stimulating hormone of male rats. Neuroimmunomodulation 12(3), 146-151.
46. C Perez Castro, A Carbia Nagashima, M Páez Pereda, V Goldberg, A Chervin, G Carrizo, et al. (2001) Effects of the gp130 cytokines ciliary neurotropic factor (CNTF) and interleukin-11 on pituitary cells: CNTF receptors on human pituitary adenomas and stimulation of prolactin and GH secretion in normal rat anterior pituitary aggregate cultures. J Endocrinol 169(3), 539-547.
47. S Theas, A De Laurentiis, M Candolfi, SL López, AE Carrasco, V Zaldivar, et al. (2001) Nitric oxide mediates the inhibitory effect of tumor necrosis factor-alpha on prolactin release. Neuroendocrinology 74(2), 82-86.
48. F Barbieri, A Bajetto, C Porcile, A Pattarozzi, G Schettini and T Florio (2007) Role of stromal cell-derived factor 1 (SDF1/CXCL12) in regulating anterior pituitary function. J Mol Endocrinol 38(3), 383-389.
49. K Francis, BM Lewis, H Akatsu, PN Monk, SA Cain, MF Scanlon, et al. (2003) Complement C3a receptors in the pituitary gland: a novel pathway by which an innate immune molecule releases hormones involved in the control of inflammation. FASEB J 17(15), 2266-2268.
50. M Markianos, ML Kosmidis and C Sfagos (2006) Reductions in plasma prolactin during acute erythropoietin administration. Neuro Endocrinol Lett 27(3), 355-358.
51. IJ Elenkov and GP Chrousos (2002) Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Ann NY Acad Sci 966 290-303.
52. Buller KM. Central pathways of immunoregulation. In: Arnason BG, Berczi I, editors; Berczi I, series editor. The brain and host defense. Neuroimmune biology, vol. 9. Amsterdam: Elsevier; 2010.
53. HO Besedovsky and A del Rey (2000) The cytokine–HPA axis feed-back circuit. Z Rheumatol 59(Suppl. 2), II/26-II/30.
54. Conti B, Tabarean I, Sanchez-Alavez M, Davis C, Brownell S, Behrens M, et al. Cytokine receptors in the brain. In: Phelps C, Korneva EA, editors; Berczi I, Szentivanyi A, series editors. Cytokines and the brain. Neuroimmune biology, vol. 6. Amsterdam: Elsevier; 2008. p. 21–38.
55. Flo T, Aderen A. Pathogen recognition by toll-like receptors. In: Bertok L, Chow DA, editors; Berczi I, Szentivanyi A, series editors. Natural immunity. Neuroimmune biology, vol. 5. Amsterdam: Elsevier; 2005. p. 167–82.
56. Y Iwasaki, T Taguchi, M Nishiyama, M Asai, M Yoshida, M Kambayashi, et al. (2008) Lipopolysaccharide stimulates proopiomelanocortin gene expression in AtT20 corticotroph cells. Endocr J 55(2), 285-290.
57. SR Bornstein, CG Ziegler, AW Krug, W Kanczkowski, V Rettori, SM McCann, et al. (2006) The role of toll-like receptors in the immune-adrenal crosstalk. Ann NY Acad Sci 1088 307-318.
58. A Katsargyris, C Klonaris, A Alexandrou, AE Giakoustidis, I Vasileiou and S Theocharis (2009) Toll like receptors in liver ischemia reperfusion injury: a novel target for therapeutic modulation? Expert Opin Ther Targets 13(4), 427-442.
59. L Shang, M Fukata, N Thirunarayanan, AP Martin, P Arnaboldi, D Maussang, et al. (2008) Toll-like receptor signaling in small intestinal epithelium promotes B-cell recruitment and IgA production in lamina propria. Gastroenterology 135(2), 529-538.
60. LK Curtiss and PS Tobias (2009) Emerging role of toll-like receptors in atherosclerosis. J Lipid Res 50(Suppl.), S340-S345.
61. SK Heo, HJ Yun, EK Noh, WH Park and SD Park (2008) LPS induces inflammatory responses in human aortic vascular smooth muscle cells via toll-like receptor 4 expression and nitric oxide production. Immunol Lett 120(1–2), 57-64.
62. E Pearlman, A Johnson, G Adhikary, Y Sun, HR Chinnery, T Fox, et al. (2008) Toll-like receptors at the ocular surface. Ocul Surf 6(3), 108-116.
63. Quintanar-Stephano A, Villalobos C, Gonzales E, Organista A, Tinajero M, Chavira R, et al. Role of the neurohypophysis on spleen cytokine MRNA expression and macrophage number in AIA. In: Abstract No. A3, Proc. VII. INSNIM congress. Rio de Janeiro; 2008. p. 34.
64. Bertók L. New prospect for the enhancement of natural immunity. In: Bertk L, Chow DA. editors; Berczi I, Szentivanyi A, series editor. Natural immunity. Neuroimmune biology, vol. 5. Amsterdam: Elsevier; 2005. p. 289–307.
65. IJ Elenkov, K Kovács, J Kiss, L Bertók and ES Vizi (1992) Lipopolysaccharide is able to bypass corticotrophin-releasing factor in affecting plasma ACTH and corticosterone levels: evidence from rats with lesions of the paraventricular nucleus. J Endocrinol 133(2), 231-236.
66. I Berczi (1994) The role of the growth and lactogenic hormone family in immune function. Neuroimmunomodulation 1 201-216.
67. V Renard, A Cambiaggi, F Vély, M Bléry, L Olcese, S Olivero, et al. (1997) Transduction of cytotoxic signals in natural killer cells: a general model of fine tuning between activatory and inhibitory pathways in lymphocytes. Immunol Rev 155 205-221.
68. RT Woodland and MR Schmidt (2005) Homeostatic proliferation of B cells. Semin Immunol 17(3), 209-217.
69. K Murali-Krishna, LL Lau, S Sambhara, F Lemonnier, J Altman and R Ahmed (1999) Persistence of memory CD8 T cells in MHC class I-deficient mice. Science 286(5443), 1377-1381.
70. K Murali-Krishna and R Ahmed (2000) Cutting edge: naive T cells masquerading as memory cells. J Immunol 165(4), 1733-1737.
71. C Ramsey, MP Rubinstein, DM Kim, JH Cho, J Sprent and CD Surh (2008) The lymphopenic environment of CD132 (common gamma-chain)-deficient hosts elicits rapid homeostatic proliferation of naive T cells via IL-15. J Immunol 180(8), 5320-5326.
72. KS Schluns, WC Kieper, SC Jameson and L Lefrançois (2000) Interleukin-7 mediates the homeostasis of naïve and memory CD8 T cells in vivo. Nat Immunol 1(5), 426-432.
73. JT Tan, B Ernst, WC Kieper, E LeRoy, J Sprent and CD Surh (2002) Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+ cells but are not required for memory phenotype CD4+ cells. J Exp Med 195(12), 1523-1532.
74. J Geginat, S Campagnaro, F Sallusto and A Lanzavecchia (2002) TCR-independent proliferation and differentiation of human CD4+ T cell subsets induced by cytokines. Adv Exp Med Biol 512 107-112.
75. NL Alves, B Hooibrink, FA Arosa and RA van Lier (2003) IL-15 induces antigen-independent expansion and differentiation of human naive CD8+ T cells in vitro. Blood 102(7), 2541-2546.
76. MM Sandau, CJ Winstead and SC Jameson (2007) IL-15 is required for sustained lymphopenia-driven proliferation and accumulation of CD8 T cells. J Immunol 179(1), 120-125.
77. JH Cho, O Boyman, HO Kim, B Hahm, MP Rubinstein, C Ramsey, DM Kim, CD Surh and J Sprent (2007) An intense form of homeostatic proliferation of naive CD8+ cells driven by IL-2. J Exp Med 204(8), 1787-1801.
78. O Alpdogan, SJ Muriglan, JM Eng, LM Willis, AS Greenberg, BJ Kappel and MR van den Brink (2003) IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation. J Clin Invest 112(7), 1095-1107.
79. DC Lenz, SK Kurz, E Lemmens, SP Schoenberger, J Sprent, MB Oldstone, et al. (2004) IL-7 regulates basal homeostatic proliferation of antiviral CD4+T cell memory. Proc Natl Acad Sci USA 101(25), 9357-9362.
80. SC Sasson, JJ Zaunders and AD Kelleher (2006) The IL-7/IL-7 receptor axis: understanding its central role in T-cell homeostasis and the challenges facing its utilization as a novel therapy. Curr Drug Targets 7(12), 1571-1582.
81. AW Goldrath, CJ Luckey, R Park, C Benoist and D Mathis (2004) The molecular program induced in T cells undergoing homeostatic proliferation. Proc Natl Acad Sci USA 101(48), 16885-16890.
82. A Jabbari and JT Harty (2005) Cutting edge: differential self-peptide/MHC requirement for maintaining CD8 T cell function versus homeostatic proliferation. J Immunol 175(8), 4829-4833.
83. EM van Leeuwen, J Sprent and CD Surh (2009) Generation and maintenance of memory CD4(+) T cells. Curr Opin Immunol 21(2), 167-172.
84. ME Blais, I Louis and C Perreault (2006) T-cell development: an extrathymic perspective. Immunol Rev 209 103-114.
85. Y Rochman and WJ Leonard (2008) The role of thymic stromal lymphopoietin in CD8+ T cell homeostasis. J Immunol 181(11), 7699-7705.
86. CD Surh, O Boyman, JF Purton and J Sprent (2006) Homeostasis of memory T cells. Immunol Rev 211 154-163.
87. MA Burchill, CA Goetz, M Prlic, JJ O’Neil, IR Harmon, SJ Bensinger, et al. (2003) Distinct effects of STAT5 activation on CD4+ and CD8+ T cell homeostasis: development of CD4+CD25+ regulatory T cells versus CD8+ memory T cells. J Immunol 171(11), 5853-5864.
88. S Ramanathan, J Gagnon, C Leblanc, R Rottapel and S Ilangumaran (2006) Suppressor of cytokine signaling 1 stringently regulates distinct functions of IL-7 and IL-15 in vivo during T lymphocyte development and homeostasis. J Immunol 176(7), 4029-4041.
89. TC Becker, SM Coley, EJ Wherry and R Ahmed (2005) Bone marrow is a preferred site for homeostatic proliferation of memory CD8 T cells. J Immunol 174(3), 1269-1273.
90. C Tian, J Bagley and J Iacomini (2007) Homeostatic expansion permits T cells to re-enter the thymus and deliver antigen in a tolerogenic fashion. Am J Transplant 7(8), 1934-1941.
91. T Schüler, GJ Hämmerling and B Arnold (2004) Cutting edge: IL-7-dependent homeostatic proliferation of CD8+ T cells in neonatal mice allows the generation of long-lived natural memory T cells. J Immunol 172(1), 15-19.
92. W Dummer, AG Niethammer, R Baccala, BR Lawson, N Wagner, RA Reisfeld, et al. (2002) T cell homeostatic proliferation elicits effective antitumor autoimmunity. J Clin Invest 110(2), 185-192.
93. C King, A Ilic, K Koelsch and N Sarvetnick (2004) Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell 117(2), 265-277.
94. R Maile, CM Barnes, AI Nielsen, AA Meyer, JA Frelinger and BA Cairns (2006) Lymphopenia-induced homeostatic proliferation of CD8+ T cells is a mechanism for effective allogeneic skin graft rejection following burn injury. J Immunol 176(11), 6717-6726.
95. VF Moxham, J Karegli, RE Phillips, KL Brown, TT Tapmeier, R Hangartner, et al. (2008) Homeostatic proliferation of lymphocytes results in augmented memory-like function and accelerated allograft rejection. J Immunol 180(6), 3910-3918.
96. SJ Lin, AT Chen and RM Welsh (2008) Immune system derived from homeostatic proliferation generates normal CD8 T-cell memory but altered repertoires and diminished heterologous immune responses. Blood 112(3), 680-689.
97. SP Hickman and LA Turka (2005) Homeostatic T cell proliferation as a barrier to T cell tolerance. Philos Trans R Soc Lond B Biol Sci. 360(1461), 1713-1721.
98. AE Troy and H Shen (2003) Cutting edge: homeostatic proliferation of peripheral T lymphocytes is regulated by clonal competition. J Immunol 170(2), 672-676.
99. S Shen, Y Ding, CE Tadokoro, D Olivares-Villagómez, M Camps-Ramírez, MA Curotto de Lafaille, et al. (2005) Control of homeostatic proliferation by regulatory T cells. J Clin Invest 115(12), 3517-3526.
100. SE Hamilton, MC Wolkers, SP Schoenberger and SC Jameson (2006) The generation of protective memory-like CD8+ T cells during homeostatic proliferation requires CD4+ T cells. Nat Immunol 7(5), 475-481.
101. SE Hamilton and SC Jameson (2008) The nature of the lymphopenic environment dictates protective function of homeostatic-memory CD8+ T cells. Proc Natl Acad Sci USA 105(47), 18484-18489.
102. KP Cheung, E Yang and AW Goldrath (2009) Memory-like CD8+ T cells generated during homeostatic proliferation defer to antigen-experienced memory cells. J Immunol 183(5), 3364-3372.
103. I Berczi and A Szentivanyi (2003) Cytokines and chemokines. I Berczi, A Szentivanyi (Eds) Neuroimmune biology, vol. 3: the immune–neuroendocrine circuitry. History and progress Amsterdam: Elsevier 191-220.
104. L Hennighausen and GW Robinson (2008) Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5B. Genes Dev 22(6), 711-721.
105. S Desrivières, C Kunz, I Barash, V Vafaizadeh, C Borghouts and B Groner (2006) The biological functions of the versatile transcription factors STAT3 and STAT5 and new strategies for their targeted inhibition. J Mammary Gland Biol Neoplasia 11(1), 75-87.
106. E Nagy and I Berczi (1989) Pituitary dependence of bone marrow function. Br J Haematol 71 457-462.
107. I Berczi and E Nagy (1991) Placental lactogen is a hemopoietic hormone. Br J Haematol 79 355-358.
108. E Nagy and I Berczi (1991) Hypophysectomized rats depend on residual prolactin for survival. Endocrinology 128 2776-2784.
109. DW Montgomery (2001) Prolactin production by immune cells. Lupus 10(10), 665-675.
110. Berczi I. Neuroimmune biology: an introduction. In: Berczi I, Gorczynski R. editors. Berczi I, Berczi I, Szetivangi A. Series editors. Neuroimmune biology, vol. 1: new foundation of biology I. Amsterdam: Elsevier; 2001. p. 3–45.
111. KW Kelley, DA Weigent and R Kooijman (2007) Protein hormones and immunity. Brain Behav Immun 21(4), 384-392.
112. I Berczi (1993) The role of prolactin in the pathogenesis of autoimmune disease. Endocrin Pathol 4 178-195.
113. RW McMurray (2001) Prolactin in murine systemic lupus erythematosus. Lupus 10(10), 742-747.
114. SE Walker (2001) Treatment of systemic lupus erythematosus with bromocriptine. Lupus 10(3), 197-202.
115. I Berczi, DA Chow, E Baral and E Nagy (1998) Neuroimmunoregulation and cancer. Int J Oncol 13 1049-1051.
116. Chattopdhyay U, Biswas R. Prolactin regulates macrophage and NK cell mediated inflammation and cytotoxic response against tumors. In: Matera L, Rapaport R, editors; Berczi I, Szentivanyi A, series editors. Growth and lactogenic hormones. Neuroimmune biology, vol. 2. Amsterdam: Elsevier; 2002. p. 227–43.
117. K Dorshkind and ND Horseman (2001) Anterior pituitary hormones, stress, and immune system homeostasis. Bioessays 23(3), 288-294.
118. CA Janeway, P Travers, M Walport and M Slomchick (2005) Immunobiology. 6th ed. Garland publishing
119. KC Wang, I Berczi, EG Hoffman and AH Sehon (1980) Effector and enhancing lymphoid cells in plasmacytoma bearing mice. II. Dynamic changes during tumor progression. Int J Cancer 25 493-501.
120. CA Akdis (2008) New insights into mechanisms of immunoregulation in 2007. J Allergy Clin Immunol. 122(4), 700-709.
121. DA Wolk and W Klunk (2009) Update on amyloid imaging: from healthy aging to Alzheimer’s disease. Curr Neurol Neurosci Rep 9(5), 345-352.
122. Berczi I, Bertok L, Chow D. Host defence: an interaction of neuroendocrine-, metabolic - and immune mechanisms in the interest of survival. In: Chow D, Bertok L, editors; Berczi I, Szentivanyi A, series editor. Natural immunity. Neuroimmune biology, vol. 5. Amsterdam: Elsevier; 2005. p. 3–25.
123. DD Taub and DL Longo (2005) Insights into thymic aging and regeneration. Immunol Rev 205 72-93.
124. I Berczi and A Szentivanyi (2004) Concluding remarks and future directions. RH Straub, E Mocchegiani, I Berczi, A Szentivanyi (Eds) The neuroendocrine immune network in ageing. Neuroimmune biology, vol. 4 Amsterdam: Elsevier 409-427.
125. Holzer P. The role of the vagus nerve in efferent signaling and homeostasis during visceral inflammation. In: Jancso G, editor; Berczi I, Szentivanyi A, series editors. Neurogenic inflammation in health and disease. Amsterdam: Elsevier; 2008. p. 321–38.